Please log in to see the full text of this API!

Abacavir

  • Synonyms: 1592U89
  • ATC: J05AF06
  • Use: Lorem  Lorem  Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:286.34 g/mol
  • CAS-RN:136470-78-5
  • InChI Key:MCGSCOLBFJQGHM-SCZZXKLOSA-N
  • InChI:InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1

Derivatives

    succinate

  • Formula: C14H18N6O • C4H6O
  • MW:356.43 g/mol
  • CAS-RN:168146-84-7

    sulfate

  • Formula: C14H18N6O • 1/2H2SO4
  • MW:670.76 g/mol
  • CAS-RN:188062-50-2

Substance Classes

Enzymes

Synthesis Path









































Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
14036-06-7 C7H14O4 acetic acid diethoxymethyl ester Methanol, diethoxy-, acetate
108-24-7 C4H6O3 acetic anhydride Acetic acid, anhydride
51471-45-5 C6H5ClN4O4 2-acetylamino-6-chloro-5-nitro-4(3H)-pyrimidinone Acetamide, N-(6-chloro-1,4-dihydro-5-nitro-4-oxo-2-pyrimidinyl)-
107-02-8 C3H4O acrolein 2-Propenal
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
D Lorem Lorem comb.
Lorem Lorem comb.
Lorem Lorem ,1999
F Lorem Lorem comb.
Lorem Lorem comb.
Lorem Lorem
GB Lorem Lorem comb.
Lorem Lorem comb.
Lorem Lorem
I Lorem Lorem comb.
Lorem Lorem
J Lorem Lorem comb. lamivudine
Lorem Lorem
USA Lorem Lorem comb. with lamivudine
Lorem Lorem comb. with lamivudine and zidovudine
Lorem Lorem
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinviduntutlaboreetdoloremagnaaliquyamerat,seddiamvoluptua.At

References

    •  Crimmins, M.T. et al.: J. Org. Chem. (JOCEAH) 61 4192 (1996).
    • b Olivo, H.F. et al.: J. Chem. Soc., Perkin Trans. 1 (JCPRB4) 1998, 391.
    • US 9 999 999 (Burroughs Wellcome; 18.2.1992; GB-prior. 27.6.1988).
    • a EP 999 999 (Wellcome Found.; 26.6.1991; appl. 21.12.1990; USA-prior. 22.12.1989).
    •  EP 9 999 999 (Solmag; appl. 5.5.2006).
    • aa EP 999 999 (Enzymatix; appl. 24.4.1991; GB-prior. 16.10.1989).
    •  US 9 999 999 (SmithKline Beecham; 22.1.2002; appl. 20.8.1998; GB-prior. 22.8.1997).
    • c US 9 999 999 (Welcome Found.; 23.7.1991; appl. 22.12.1989; GB-prior. 27.6.1988).
    • d WO 9 999 999 (Glaxo; appl. 12.11.1998; WO-prior. 12.11.1997).
  • alternative syntheses:

    • EP 999 999 (Lonza; appl. 13.5.1998; CH-prior. 13.5.1997).
  • preparation of chloropyrimidine intermediate V:

    • US 9 999 999 (SmithKline Beecham; 10.9.2002; appl. 3.2.1995; GB-prior. 4.2.1994).
  • condensation of pyrimidines with cyclopentylamine IV:

    • Vince, R.; Hua, M.: J. Med. Chem. (JMCMAR) 33 (1), 17 (1990).
    • Grumam, A. et al.: Tetrahedron Lett. (TELEAY) 36 (42), 7767 (1995).
    • EP 999 999 (Wellcome Found.; appl. 26.6.1989; GB-prior. 27.6.1988).
    • EP 999 999 (Wellcome Found.; appl. 23.10.1989; GB-prior. 24.10.1988).
    • US 9 999 999 (SmithKline Beecham; 11.11.2003; appl. 14.10.1998; GB-prior. 14.10.1997).
    • JP 9 999 999 (Asahi Glass Co.; appl. 17.7.1987).
  • alternative preparation of 4-amino-2-cyclopentene-1-methanol:

    • EP 999 999 (Lonza; appl. 24.11.1998; CH-prior. 27.11.1997).
    • WO 9 999 999 (Lonza; appl. 30.5.1997; CH-prior. 30.5.1996).
    • WO 9 999 999 (Glaxo; 4.3.1999; GB-prior. 20.8.1998).
    • WO 9 999 999 (Glaxo; 11.6.1998; GB-prior. 7.12.1996).
    • WO 9 999 999 999 (Chirotech; 15.3.2001; GB-prior. 9.9.1999).
  • abacavir hemisulfate salt:

    • US 9 999 999 (Glaxo Wellcome; 25.9.2001; appl. 14.5.1998; GB-prior. 17.5.1997).
  • abacavir succinate as antiviral agent:

    • WO 9 999 999 (Wellcome; 7.3.1996; appl. 25.8.1995; GB-prior. 26.8.1994).
  • pharmaceutical formulations:

    • US 9 999 999 (SmithKline Beecham; 4.11.2003; appl. 4.2.1999; GB-prior. 6.2.1998).
  • synergistic combinations for treatment of HIV infection:

    • WO 9 999 999 (Wellcome; 3.10.1996; appl. 28.3.1996; GB-prior. 30.3.1995).